Market revenue in 2023 | USD 181.9 million |
Market revenue in 2030 | USD 365.1 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 37.16% in 2024. Horizon Databook has segmented the Mexico biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is one of the largest biotechnology markets in Latin America. The country has emerged as a potential hub for biopharmaceutical products owing to the presence of skilled scientists, low manufacturing costs, and an advanced legal framework.
Moreover, the high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology and biomanufacturing sectors. In addition, the country’s government has prioritized growth and innovation in the biopharmaceutical space.
Thus, growing biopharmaceutical and biotechnology industries in the country are anticipated to create high demand for biochip and array-based technologies in the region and support market growth. However, limited R&D investments may hamper the market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico biochip market, including forecasts for subscribers. This country databook contains high-level insights into Mexico biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account